This guide covers what scientists are working on, how far the research has come, and what proven GLP-1 options you can access right now
Results vary based on dosage, metabolism, and lifestyle habits, but most patients experience steady progress rather than extreme or unhealthy weight changes
Exenatide was studied in Parkinsons disease : a 2017 Lancet trial showed that patients on weekly exenatide had a slight improvement in motor scores compared to placebo ( [142] )
Commonly used to boost hydration, energy, and immune support, IV drips are ideal for individuals looking to improve overall wellness and counteract the effects of stress, fatigue, or poor diet
Moderate-intensity aerobic exercise may support metabolic health and potentially affect GLP-1 secretion, though the relationship is complex
Free from fillers and ballast substances, each dose contains concentrated nutrients